Table 1. Baseline characteristics and association with antiretroviral therapy in included patients.
| n (%) | Treated with ART: | ||||
|---|---|---|---|---|---|
| Early (<8 weeks) | Late (>8 weeks) | Not started (at one year) | p-value | ||
| Total | 404 | 122 | 156 | 126 | |
| Age (years) | |||||
| Median age (Interquartile range) | 32.0 (24.0 – 39.8) | 34.5 (28.0 – 41.3) | 31.0 (23.0 – 40.0) | 30.0 (20.0- 36.0) | 0.003 |
| <18 18-30 31-50 >50 |
77 (19.1) 110 (27.2) 181 (44.8) 36 ( 8.9) |
17 ( 13.9) 24 (19.7) 70 (57.4) 11 (9.0) |
31 (19.9) 46 (29.5) 67 (42.9) 12 (7.7) |
29 (23.0) 40 (31.7) 54 (42.9) 3 (2.4) |
0.395 |
| CD4 count at start of TB treatment † | |||||
| Median CD4 (Interquartile range) | 122 (41- 295) | 92 (30 – 172) | 130 (48-277) | 241 (41 – 476)) | <0.001 |
| <= 50 51-200 201-350 > 350 |
107 (29.6) 122 (33.7) 59 (16.3) 74 (20.4) |
42 (35.9) 52 (44.4) 16 (13.7) 7 (6.0) |
38 (26.4) 50 (24.7) 30 (20.8) 26 (18.1) |
27 (26.7) 20 (19.8) 13 (12.9) 41 (40.6) |
<0.001 |
| Gender | |||||
| Male Female |
192 (47.5) 212 (52.5) |
60 (49.2) 62 (50.8) |
73 (46.8) 83 (53.2) |
59 (46.8) 67 (53.2) |
0.92 |
| Type of TB | |||||
| Smear positive pulmonary Smear negative pulmonary Extrapulmonary |
83 (20.5) 285 (70.5) 36 ( 8.9) |
20 (16.4) 93 (76.2) 10 (7.4) |
31 (19.9) 108 (69.2) 17 (10.9) |
32 (25.4) 84 (66.7) 10 (7.9) |
0.281 |
| Type of Patient ‡ | |||||
| New patient Retreatment Transfer in |
338 (83.7) 54 (13.4) 10 ( 2.5) |
101 (82.8) 15 (12.3) 5 (4.1) |
128 (82.1) 24 (15.4) 4 (2.6) |
109 (86.5) 15 (11.9) 1 (0.8) |
0.490 |
†
not recorded for 42 patients
‡
not recorded for 2 patients